Full-Time
Updated on 9/3/2026
Private markets investment management for institutions
No salary listed
Conshohocken, PA, USA
In Person
Bachelor's, MBA
See people who can refer or advise you
Hamilton Lane provides tailored exposure to private markets for institutional and private wealth investors worldwide, combining bespoke portfolio solutions with strong client service. Its product works by offering access to private markets investments through a disciplined, data-driven investment process, backed by years of research, risk analytics, and manager selection to build customized portfolios. The company differentiates itself from peers through a long track record (over 33 years) of client-centricity, candor, authenticity, and rigorous, data-supported insights, delivering solutions-focused strategies and high-touch service. Its goal is to improve the financial well-being of clients who depend on it by helping them access and navigate the private markets in a thoughtful, transparent way.
Company Size
201-500
Company Stage
IPO
Headquarters
Lower Merion Township, Pennsylvania
Founded
1991
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Mental Health Support
Tuition Reimbursement
Paid Vacation
Paid Sick Leave
401(k) Retirement Plan
Employee Stock Purchase Plan
Wellness Program
Hamilton Lane reported strong first-quarter results with revenue climbing 56% year-over-year to $275.3 million and fee-related earnings up 49% to $124.5 million. The firm's total assets surpassed $1.1 trillion. Fee-earning assets in specialised funds grew 25% to $42.6 billion, pushing the blended fee rate to 69 basis points. The Evergreen platform generated $640 million in net inflows, ending the quarter with $19 billion in assets. However, the firm acknowledged challenges with client flows. Its non-US multi-strategy equity fund experienced net outflows, reflecting broader investor hesitancy. Co-CEO Erik Hirsch noted "a slowdown in flows on certain products and the general hesitancy with investors." Closed-end fundraising remained robust, with the sixth direct equity fund closing at $3.8 billion.
Top growth stocks to research - september 2nd. September 2, 2026 Key points. * MarketBeat identified seven growth stocks to research: Prologis, Ascendis Pharma, Teledyne Technologies, Jersey Mike's, Hamilton Lane, Hercules Capital, and Pershing Square, selected for having the highest recent dollar trading volume among growth stocks. * The companies span several industries, including logistics real estate, biotechnology, industrial technology, restaurants, private equity, venture lending, and alternative asset management. * Several highlighted businesses are pursuing expansion through specialized growth strategies, such as Prologis's global logistics portfolio, Ascendis Pharma's rare-disease pipeline, Jersey Mike's franchising, and Pershing Square's compounding assets under management. * MarketBeat previews the top five stocks to own by October 1st. Prologis, Ascendis Pharma A/S, Teledyne Technologies, Jersey Mike's, Hamilton Lane, Hercules Capital, and Pershing Square are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies that investors expect to expand their revenue, earnings, or market presence faster than the broader market. These companies often reinvest profits into their businesses rather than paying large dividends, and their shares may carry higher valuations and greater risk because future growth is not guaranteed. These companies had the highest dollar trading volume of any Growth stocks within the last several days. Prologis (PLD). Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries. Ascendis Pharma A/S (ASND). Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. Teledyne Technologies (TDY). Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters. Discover more Options Profit Calculator Jersey Mike's (JMKE). We are Jersey Mike's: A high-growth franchisor of fast casual, submarine-style sandwich restaurants specializing in authentic, hand-crafted, craveable subs. Built over 70 years on one uncompromising belief - that a truly great sub sandwich can change your day and that a truly great brand changes its community - Jersey Mike's is now one of the largest and fastest-growing limited-service restaurant brands based on U.S. Hamilton Lane (HLNE). Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services. Hercules Capital (HTGC). Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. Pershing Square (PS). We are an alternative asset management company that manages pools of permanent capital invested in long-term, high-return investment strategies. Our growth is principally driven by the long-term compounding of our assets under management and the opportunistic launch of new permanent capital vehicles that enable us to pursue new investment verticals or to pursue our core investment strategies in new jurisdictions. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Continue following MarketBeat Before you consider Prologis, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prologis wasn't on the list. While Prologis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Hamilton Lane reported second quarter results that significantly exceeded analyst expectations. The private markets investment firm posted revenue of $275.3 million, beating estimates by 21%, with adjusted earnings per share of $1.94, surpassing forecasts by 22.2%. The quarter's strong performance was driven by robust net inflows across its Evergreen product suite and success in securing new mandates. CEO Erik Hirsch highlighted particularly strong performance in multi-strategy equity and credit offerings. Operating margin improved to 45.9%, up from 43.7% in the prior year period. Adjusted EBITDA reached $154.2 million, representing a 56% margin and exceeding analyst estimates by 28.3%. During the earnings call, analysts focused on questions regarding the firm's Global Private Asset Fund returning to net inflows, redemption impacts on international Evergreen funds, tokenization's potential to transform private markets, and the sustainability of fee-related earnings margins.
Hamilton Lane, an alternative investment management firm, is set to report its second-quarter earnings on Tuesday before market open. The market expects the company's revenue to grow 29.3% year-on-year, reversing the 10.6% decrease recorded in the same quarter last year. In the previous quarter, Hamilton Lane reported revenues of $193.6 million, down 2.2% year-on-year, missing analysts' revenue expectations. However, the company beat earnings per share estimates. Analysts have generally reconfirmed their estimates over the last 30 days. The company has missed Wall Street's revenue estimates multiple times over the past two years. Hamilton Lane's share price has risen 6.5% over the last month, outperforming the custody bank segment average of 2.4%. The stock currently trades at $89.66, below the average analyst price target of $126.86.
Is Hamilton Lane (HLNE) using Savant deal to redefine its Wealth Management and risk profile? The punchline. Hamilton Lane has committed a $270 million minority stake in Savant Wealth Management, a move aimed at enhancing its position in the wealth management sector. This single-asset continuation vehicle is designed to provide liquidity to Savant's early partners while maintaining existing minority holders. Why you should read this. This article offers valuable insights into Hamilton Lane's strategic moves within the wealth management landscape and illustrates trends in private equity investments. Who this is for. This article is targeted at institutional investors, wealth management professionals, and financial advisors who are interested in developments in private equity and wealth management strategies. Investor implications. The implications of this deal suggest a growing trend towards complex continuation structures in wealth management, signaling potential opportunities and risks for investors and asset managers in navigating evolving market environments. Read the full article. For complete coverage and additional details, visit the original article published by simplywall.st.